Trial site
Rio de Janeiro
- 11running trials
- 9closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia5 trials
- Coronary artery disease3 trials
- Familial hypercholesterolaemia3 trials
- Multiple sclerosis3 trials
- Stroke3 trials
- Childhood cancers2 trials
- Heart failure2 trials
- Lupus (SLE)2 trials
- Acute lymphoblastic leukaemia1 trial
- Aortic stenosis1 trial
- Gastric and oesophageal cancer1 trial
- Lung cancer1 trial
- and 3 more
- Phase
- Phase 314 trials
- Phase 23 trials
- Phase 42 trials
- Status
- Completed8 trials
- Active, not recruiting7 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals20 trials
Running trials
Active, not recruiting
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- Lupus (SLE)1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026